P. Deligiannis

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Dr. P. Deligiannis is a leading urologic oncologist whose research focuses on the surgical management of recurrent prostate cancer, with a particular emphasis on salvage therapies. His major contribution lies in advancing the understanding of salvage radical prostatectomy as a viable treatment option for patients who experience biochemical recurrence after primary radiotherapy or other focal therapies. In his comprehensive 2024 review, Dr. Deligiannis synthesizes contemporary evidence on patient selection, surgical techniques, and oncologic outcomes, demonstrating that salvage prostatectomy can offer durable cancer control in carefully chosen candidates. This work has already garnered 4 citations, reflecting its immediate impact on clinical decision-making. Beyond this landmark review, his research portfolio explores the evolving landscape of multimodal treatments for prostate cancer, including comparisons of whole-gland and focal ablative novel therapies. Dr. Deligiannis’s scholarship bridges the gap between surgical innovation and practical patient care, providing essential guidance for urologists navigating the complexities of recurrent disease. His ongoing contributions continue to shape treatment paradigms, offering renewed hope for patients facing limited options after initial therapy failure.